drugset / Trial / NCT00861016

Efficacy and Safety of Metoprolol Succinate Prolonged-Release Tablet in Patients With Mild to Moderate Hypertension

NCT00861016

Phase 4 Completed 310 enrolled AstraZeneca
NaSingle-groupOpen-labelTreatment

Summary

This is an open-label, non-comparative, multi-centre clinical study to evaluate the Efficacy and safety of Metoprolol Succinate prolonged-release tablet (Betaloc Zok) in patients with mild to moderate essential hypertension.

Timeline

Start
2005-10
Primary completion
2006-04
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Felodipine Small molecule 5 mg Oral
Subject Metoprolol Other / unclassified 95 mg Oral